
Summary:
New clinical trial execution models have been introduced over the last decade, providing local communities with more direct access to clinical research through remote sites, retail pharmacies, mobile units, site staff embedded in clinical care settings, and more.
In this session, recorded at the 2024 CRAACO: Clinical Research as a Care Option conference, Joan Chambers of the Tufts Center for the Study of Drug Development shared preliminary survey results conducted by the Tufts CSDD to help industry understand the strategic and structural growth of new trial sites and partnerships in bringing trials directly to local communities.
This podcast sheds light on the strategic and structural growth of these new trial sites and partnerships, offering valuable insights into the evolving global clinical trial landscape.
For more information, go to theconferenceforum.org
In this podcastRelated Podcasts
View All
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives

Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges

Directors' Talk DPHARM 2025 - Pharma from the Trenches; Part II
